1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGraduate Medical Education (GME): Neuro-Oncology Fellowship is sponsored by National Institutes of Health (NIH) Clinical Center. Integrated clinical research fellowship in neuro-oncology between NIH and Johns Hopkins University.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Graduate Medical Education (GME): Neuro-Oncology | Research Funding National Institutes of Health Graduate Medical Education (GME): Neuro-Oncology The Neuro-Oncology fellowship program is designed to train academic Neuro-Oncologists and physician scientists across a range of medical subspecialties to be specialized in both clinical practice and/or research in Neuro-Oncology.
It is a single, integrated clinical research fellowship training program in Neuro-Oncology between the Neuro-Oncology Branch (NOB), Center for Cancer Research (CCR), National Cancer Institute (NCI) and the Johns Hopkins University (JHU) School of Medicine Department of Oncology. The joint program is the NCI/JHU Neuro-Oncology Fellowship Training Program.
Trainees may participate in the program for one to three years, depending on the goals of the individual candidate. In order to train candidates that are at varied levels of clinical training and research backgrounds, two fellowship tracks are offered through the NCI/JHU Neuro-Oncology Fellowship Training Program.
Research Track : Fellows participating in the two-year Research Track will participate in research projects that include development, data analysis, and manuscript preparation of clinical trial work conducted by the NOB. They will be required to initiate at least one thoughtful investigative question that may be turned into an independent study using the wealth of patient data available from the clinic population.
They will also prepare at least one study for submission to a national scientific meeting and as a manuscript for publication in a peer reviewed journal.
Fellows in the Research Track will be required to complete the Introduction to the Principles and Practice of Clinical Research (IPPCR), Writing Cancer Grant Applications (WCGA), and Statistical Analysis of Research Data (SARD) courses offered by the NIH Clinical Center and Center for Cancer Research (CCR).
The goal by the end of their two-year term is to be able to complete an application for a peer reviewed funding mechanism aimed towards supporting a career as an independent investigator in Neuro-Oncology. United Council for Neurologic Subspecialties (UCNS) Track : This is a three-year track, including two years of clinical or translational research in Neuro-Oncology and one year of clinical training to complete the UCNS curriculum.
This track is open to board-eligible or board-certified Neurologists who are interested in acquiring subspecialty expertise in the clinical practice of Neuro-Oncology translational research. This track has limited slots available. Medical - Clinical Science
According to the current listing, eligibility includes: Medical graduates seeking specialization in neuro-oncology. Confirm the full requirements in the official notice before applying.
Graduate Medical Education (GME): Neuro-Oncology Fellowship is funded by National Institutes of Health (NIH) Clinical Center. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.
Read articleNIH released a draft policy on August 27, 2026 that would require every NIH-supported clinical study to offer participants a plain-language summary of results — clinical trials within one year of completion, all other clinical research by the end of the funding period. It covers observational and behavioral research that ClinicalTrials.gov never touched. Here is the scope, the four requirements nobody has budgeted for, and what to say before the October 26 deadline.
Read articleNOT-OD-26-098 bars K award funds from supporting clinical trials, feasibility studies, and ancillary studies for due dates on or after October 12, 2027, and retires the Independent Clinical Trial Required K NOFOs. NIH has no replacement mechanism yet — only an RFI closing September 30, 2026. Here is what the policy actually says, who it hits, and how to sequence around it.
Read article